Literature DB >> 27921164

M-type phospholipase A2 receptor (PLA2R) glomerular staining in pediatric idiopathic membranous nephropathy.

Shoichiro Kanda1, Shigeru Horita2, Takeshi Yanagihara3, Akira Shimizu4, Motoshi Hattori5.   

Abstract

BACKGROUND: Identifying M-type phospholipase A2 receptor (PLA2R) is a landmark breakthrough for understanding adult idiopathic membranous nephropathy (iMN). However, potential roles for PLA2R in pediatric iMN have not been well investigated.
METHODS: A total of 34 pediatric iMN patients who underwent kidney biopsy between 1972 and 2015 were enrolled in this study. The study cohort consisted of 15 children aged from 3 to 9 years and 19 aged from 10 to 15 years. In all cases, secondary causes of MN, including infections, autoimmune diseases, and others, were ruled out. We examined PLA2R glomerular staining in stored, formalin-fixed, paraffin-embedded kidney biopsy samples. Kidney biopsy specimens obtained from an adult patient with iMN and an adult patient with lupus-associated MN were also examined to assess our PLA2R staining procedure.
RESULTS: Granular staining of PLA2R along glomerular capillary loops was present in two patients: an 11-year-old girl and 12-year-old boy identified during a school urine screening test and who presented with mild proteinuria at the time of biopsy. Interestingly, the intensity of PLA2R glomerular staining in these patients was weaker than that of a PLA2R-positive adult iMN patient. There were no PLA2R-positive patients among our cohort of children younger than 10 years.
CONCLUSIONS: This preliminary study suggests PLA2R may play a role in some adolescent and preteen iMN patients but may be less frequently associated with iMN during childhood.

Entities:  

Keywords:  Biopsy; Idiopathic membranous nephropathy; PLA2R glomerular staining; Pediatric

Mesh:

Substances:

Year:  2016        PMID: 27921164     DOI: 10.1007/s00467-016-3552-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Phospholipase A2 receptor staining is absent in many kidney biopsies with early-stage membranous glomerulonephritis.

Authors:  Margaret S Ryan; Anjali A Satoskar; Gyongyi M Nadasdy; Sergey V Brodsky; Jessica A Hemminger; Tibor Nadasdy
Journal:  Kidney Int       Date:  2016-06       Impact factor: 10.612

2.  Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy.

Authors:  Hua-Zhang Qin; Ming-Chao Zhang; Wei-Bo Le; Qiang Ren; Da-Cheng Chen; Cai-Hong Zeng; Lei Liu; Ke Zuo; Feng Xu; Zhi-Hong Liu
Journal:  J Am Soc Nephrol       Date:  2016-03-17       Impact factor: 10.121

3.  Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy.

Authors:  L Nicholas Cossey; Patrick D Walker; Chris P Larsen
Journal:  Pediatr Nephrol       Date:  2013-08-02       Impact factor: 3.714

4.  PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.

Authors:  Hanna Debiec; Pierre Ronco
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

5.  Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.

Authors:  Elion Hoxha; Ursula Kneißler; Gesa Stege; Gunther Zahner; Ina Thiele; Ulf Panzer; Sigrid Harendza; Udo M Helmchen; Rolf A K Stahl
Journal:  Kidney Int       Date:  2012-06-06       Impact factor: 10.612

6.  Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.

Authors:  Norifumi Hayashi; Shin'ichi Akiyama; Hiroshi Okuyama; Yuki Matsui; Hiroki Adachi; Hideki Yamaya; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

7.  Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.

Authors:  Barbora Svobodova; Eva Honsova; Pierre Ronco; Vladimir Tesar; Hanna Debiec
Journal:  Nephrol Dial Transplant       Date:  2012-12-06       Impact factor: 5.992

8.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

Review 9.  Membranous nephropathy: not just a disease for adults.

Authors:  Rivka Ayalon; Laurence H Beck
Journal:  Pediatr Nephrol       Date:  2013-12-29       Impact factor: 3.714

Review 10.  Membranous nephropathy in children: clinical presentation and therapeutic approach.

Authors:  Shina Menon; Rudolph P Valentini
Journal:  Pediatr Nephrol       Date:  2009-11-12       Impact factor: 3.714

View more
  6 in total

1.  Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents.

Authors:  Anne K Dettmar; Thorsten Wiech; Markus J Kemper; Armin Soave; Michael Rink; Jun Oh; Rolf A K Stahl; Elion Hoxha
Journal:  Pediatr Nephrol       Date:  2017-10-15       Impact factor: 3.714

Review 2.  Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era.

Authors:  Luisa Safar-Boueri; Albina Piya; Laurence H Beck; Rivka Ayalon
Journal:  Pediatr Nephrol       Date:  2019-12-06       Impact factor: 3.714

Review 3.  Genetics of membranous nephropathy.

Authors:  Sanjana Gupta; Anna Köttgen; Elion Hoxha; Paul Brenchley; Detlef Bockenhauer; Horia C Stanescu; Robert Kleta
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992

4.  Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN).

Authors:  Michelle M O'Shaughnessy; Jonathan P Troost; Andrew S Bomback; Michelle A Hladunewich; Isa F Ashoor; Keisha L Gibson; Raed Bou Matar; David T Selewski; Tarak Srivastava; Michelle N Rheault; Amira Al-Uzri; Amy J Kogon; Myda Khalid; Suzanne Vento; Neil S Sanghani; Brenda W Gillespie; Debbie S Gipson; Chia-Shi Wang; Afshin Parsa; Lisa Guay-Woodford; Louis-Philippe Laurin
Journal:  Kidney Int Rep       Date:  2019-09-16

5.  Lung cancer patients with nephropathy as the first manifestation: Literature review and clinical study report.

Authors:  Qianqian Xu; Guming Zou; Li Zhuo; Hongmei Gao; Wenge Li
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

Review 6.  Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.

Authors:  Andreas Kronbichler; Jun Oh; Björn Meijers; Gert Mayer; Jae Il Shin
Journal:  Biomed Res Int       Date:  2017-08-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.